News & Media :: Vedanta Biosciences, Inc.

Aug 5, 2020

Racing the clock to stop drug-resistant superbugs

Recent News

Jul 8, 2020

Microbiome therapeutics and patent protection

Jun 9, 2020

Vedanta Biosciences Announces Positive Topline Data from Two Phase 1 Studies of VE202, a Rationally Defined Bacterial Consortium Being Advanced for Inflammatory Bowel Diseases (IBD)

Feb 7, 2020

Drugs From Bugs: Why Gates, Zuck And Benioff Think The Next Blockbusters Will Come From Inside Your Gut

Jan 29, 2020

Fighting Cancer with Microbes

View All News View All Press Releases